S&P 500 Futures
(0.06%) 5 524.75 points
Dow Jones Futures
(0.16%) 39 532 points
Nasdaq Futures
(-0.01%) 19 925 points
Oil
(0.49%) $81.94
Gas
(-0.88%) $2.58
Gold
(-0.12%) $2 336.70
Silver
(-0.17%) $29.51
Platinum
(-1.07%) $1 003.20
USD/EUR
(-0.43%) $0.929
USD/NOK
(-0.46%) $10.63
USD/GBP
(-0.20%) $0.789
USD/RUB
(1.34%) $86.87

Realaus laiko atnaujinimai Sarepta Therapeutics, [0L35.L]

Birža: London Stock Exchange Sektorius: Healthcare Pramonė: Medical - Pharmaceuticals
Atnaujinta28 birž. 2024 @ 20:55

1.37% $ 158.65

Live Chart Being Loaded With Signals

Commentary (28 birž. 2024 @ 20:55):
Our systems believe the stock currently is overvalued by -1.25% compare to its pairs and should correct downwards.
Profile picture for Sarepta Therapeutics, Inc.

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases...

Stats
Šios dienos apimtis 351
Vidutinė apimtis 424
Rinkos kapitalizacija 15.00B
EPS $0.380 ( Q1 | 2024-05-01 )
Kita pelno data ( $0 ) 2024-07-30
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -37.02
(Sector) 0
(Industry) 0
ATR14 $1.006 (0.64%)